<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04165460</url>
  </required_header>
  <id_info>
    <org_study_id>019/026/ICI, CEI/1330/18</org_study_id>
    <secondary_id>INCAN</secondary_id>
    <nct_id>NCT04165460</nct_id>
  </id_info>
  <brief_title>Effect of Two Cognitive-Behavioral Interventions on Cervical Cancer Patients</brief_title>
  <official_title>Effect of Two Cognitive-Behavioral Interventions on Psychosocial Factors and Quality of Life of Cervical Cancer Patients With Locally-advanced and Advanced Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Cancerología</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institute of Cancerología</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cancer represents the second cause of death in general population worldwide and according to
      statistics, it is expected to increase in the next 20 years. Cervical cancer is the fourth
      cause of morbidity and mortality among women around the world. Late diagnosis and treatment
      indices several emotional reactions in patients leading to psychological disorders with an
      impact in quality of life. Anxiety and depression are the most frequent emotional reactions
      in cancer patients, which may vary depending on psychosocial factors such as coping and
      family support, mostly provided by the primary caregiver. Despite the high psychological
      morbidity in cancer patients, it is estimated that, among those patients needing
      psychological support, only 10% receive such interventions. A growing interest on
      psychological interventions in oncology has increased in the last 40 years, however, scarce
      investigations have been performed, especially in cervical cancer patients. The
      Cognitive-Behavioral Therapy has proven to be beneficial in general cancer population
      decreasing the psychological symptoms and improving the quality of life. Thus, the aim of
      this study is to evaluate the effect of two Cognitive-Behavioral psychological interventions
      on anxiety, depression, coping, therapeutic adherence, sexual satisfaction and quality of
      life of cervical cancer patients with locally-advanced and advanced disease attended at the
      National Cancer Institute from Mexico. Psychological intervention will be provided during ten
      weekly sessions including psychoeducation, relaxation, cognitive restructuring and problem
      solving with a pretest, posttest performed one week after intervention, and finally a follow
      up after three months after finishing the psychological intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cervical cancer is the fourth cause of morbidity and mortality worldwide, being one of the
      most important threats to women's health. More than 83,000 women were diagnosed with cervical
      cancer and 36,000 died in the Region of the Americas in 2012. This phenomenon will increase
      by 45% for 2030.

      During the natural history of Cervical cancer, and as a consequence of therapeutic
      approaches, a certain proportion of the patients may have emotional reactions leading to
      psychological disorders, as severe as those disease complications, which also deteriorate
      their quality of life. The most frequent reactions are anxiety and depression. These may vary
      depending on different psychosocial factors, including coping and social support, mostly
      provided by the Primary Caregiver, who has a fundamental role in hospital and home care,
      helping on therapeutic adherence.

      Therapeutic adherence is essential in order to obtain optimal results of the given
      oncological treatment, representing a mediating variable with important implications for
      survival, disease progression and in the improving of quality of life.

      Response to treatment has been widely evaluated by tumor size, OS and DFS. Nevertheless, in
      the past tree decades the evaluation of Quality of Life has risen as an indicator of
      therapeutic response. Quality of life is an indicator that measures the general well-being of
      the patients according to the overall effects of the oncological treatments. Scientific
      evidence reports that cervical cancer survivors may have a worst quality of life as well as
      other physical and emotional symptoms than those observed in other cancer populations. Hence,
      it is necessary to focus on psychological interventions aimed to improve the quality of life
      and to decrease the psychological morbidity in cervical cancer patients.

      During the last four decades a special interest in psychosocial interventions in oncology
      population has risen, establishing that Cognitive-Behavioral Therapy is beneficial in the
      reduction of physical and emotional symptoms of patients, promoting the adaptive coping and
      improving the quality of life.

      Few evidences exist about psycho-social factors prevalence on gynecological cancer patients.
      The current available studies have grouped different types of gynecological cancer including
      breast, ovary, endometrium and vulva, but cervical cancer has been included only in a small
      proportion of those studies producing a certain degree of bias at the time of interpreting
      the results. Moreover, most of the studies has focused in breast and ovarian cancer patients.
      However, it has been proposed the existence of differences in psychological morbidity in
      women with cervical cancer, therefore is essential to focus our efforts in this particular
      population due to its high morbidity and mortality.

      Hypothesis Patients with locally advanced and advanced cervical cancer receiving &quot;A&quot;
      psychological intervention will have a greater decrease in anxiety, depression, better coping
      responses, sexual satisfaction, therapeutic adherence and quality of life compared with the
      &quot;B&quot; psychological intervention.

      The general aim of this study is to evaluate the effect of two cognitive-behavioral
      interventions on psycho-social factors and quality of life of cervical cancer patients with
      locally advanced and advanced disease.

      Specific objectives:

        1. To identify and to compare the degree of the psychosocial variables: anxiety,
           depression, coping responses, therapeutic adherence and sexual satisfaction at different
           evaluation phases (pre-intervention, post-intervention and follow-up) in cervical cancer
           patients.

        2. To evaluate and to compare the health-related quality of life perceived at different
           evaluation phases (pre-intervention, post-intervention and follow-up) in cervical cancer
           patients.

      Exploratory objectives:

        1. To evaluate the degree of anxiety, depression, quality of life and the presence of
           Caregiver Burden Syndrome in primary caregivers before the psychological treatment given
           to cervical cancer patients.

        2. To evaluate the association between psychological variables of the primary caregiver and
           the emotional distress and quality of life of their locally advanced and advanced
           cervical cancer patients.

      METHODS

      Study Design: This a prospective, experimental, longitudinal, open and randomized study

      Study population: patients will be divided into two treatment groups (&quot;A&quot; and &quot;B&quot;) for
      pre-intervention, post-intervention and a three months follow-up evaluation treated at the
      National Cancer Institute from Mexico.

      Sample size:

      According to the criteria of two proportions, a sample of 92 cervical cancer patients (two
      intervention groups) and their matched primary caregivers (92) was obtained.

      Statistical analysis:

      The processing and analysis of the database will be carried out with the SPSS version 22.0®
      package for Microsoft.

        -  Univariate analysis will be carried out to describe the study population. Descriptive
           statistics will be used to obtain measures of central tendency and dispersion, for
           continuous variables depending on their distribution, mean and standard deviation
           (parametric) or median and interquartile range (non-parametric) may be reported. For
           qualitative variables, the distribution of absolute and relative frequencies will be
           reported.

        -  Group homogeneity analysis: the general characteristics of the patients in both
           intervention groups will be evaluated to asses the balance and homogeneity. For
           quantitative variables t-Student of independent samples or U of Mann-Whitney will be
           used. For qualitative variables Chi-Square or Chi-Square trends will be used.

        -  To estimate the change in the variables of interest throughout the measurements in both
           intervention groups, ANOVA analysis of repeated measures or Friedmand will be carried
           out.

        -  To determine the clinical intra-subject changes, an analysis of individual replicates
           will be performed analyzing the pre-intervention, post-intervention and after
           three-month follow-up evaluation.

      Procedure:

      Patients affiliated to the MICAELA Program referred to the Psychooncology service will be
      considered as candidates for the study.

      Informed consent obtention: after reading the Informed Consent, patients will be informed
      that their participation will consist on answering questionnaires for psychological
      assessment and psychological attention, if required. If the patient agree to participate, she
      will sign the Informed Consent document. A semi-structured interview will be applied to
      obtain socio-demographic and familiar psycho-pathological disorders history. Then,
      psychometric instruments will be applied.

      Patients who are detected with distress or maladaptive coping will be randomized to one of
      the two interventions groups.

      There will be scheduled ten weekly sessions of one hour approximately in with &quot;A&quot;
      Intervention or &quot;B&quot; Intervention will be applied according the group assigned by
      randomization. Then, patients will be scheduled for psychological treatment appointments and
      for evaluation after finishing treatment.

      Ethical considerations:

      Participants will be informed about details regarding the study, through the Informed Consent
      process. Patients that desire to participate will express their willingness with the sign of
      the Informed Consent document. Patients could leave the study at any time when desire.

      The study will be conducted according to the ethical principles established in the documents
      adopted by the international community as declared at the Good Clinical Practices, the
      Nuremberg Code, the Declaration of Helsinki as well as the Guide of Good Clinical Practices
      of the Conference Harmonization International and anyone who represents the greatest
      protection for the individual.

      According to the regulations of the General Health Law on Health Research, the second title
      on the Ethical Aspects of Research in Human Beings, Chapter I, Article 17, paragraph III, the
      proposed interventions on this study are considered as risk-free.

      Protocol and Informed Consent have been approved by Institutional Research and the Ethics
      Committees.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 2, 2020</start_date>
  <completion_date type="Anticipated">February 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Anxiety and Depression</measure>
    <time_frame>Six months</time_frame>
    <description>Change in Hospital Anxiety and Depression Scale total score and in the two Subescales
The Hospital Anxiety and Depression Scale (HADS-M) for Mexican patients. HADS was especially designed to detect anxiety and depression states of patients with chronic diseases. HADS-M is a HADS-modified version that has been validated in an oncological sample of patients in Mexican population. HADS-M comprises 12 items measured in a 0-3-point Likert scale, divided into two subescales, one for depression and one for anxiety. The validated version in Mexico has an internal consistency of alpha= 0.86 for global scale, and 0.79 for depression and 0.80 for anxiety subscales. Compared to other instruments, it has sensitivity to detect therapeutic changes associated to psychological interventions. The subscales score is categorized in without (0-5), low (6-8), moderate (9-11), and severe (12 or more) anxiety or depression.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in coping style</measure>
    <time_frame>Six months</time_frame>
    <description>Change in the Brief COPE-17 Inventory subescales scores
The Brief COPE Inventory (COPE-17). Is a brief version of the COPE Inventory (Carver, et al., 1989). It has 17 items measured in a 0-3 point Likert scale, to evaluate coping strategies, that are grouped in seven subescales (planning, self-distraction, humor, seeking for social support, substance use, emotional-religious-spiritual support and self-blame). COPE-17 determines two primary coping styles either as approach coping or avoidant coping. It was adapted and validated in Mexico on a breast cancer population (Ornelas, et al., 2013), obtaining an internal alpha consistency of 0.70 either for the general scale and for each subescale. Avoidant Coping is characterized by the subscales of self-distraction, substance use and self-blame. Approach Coping is characterized by the subscales of planning and seeking for social support. Humor and Emotional-Religious-spiritual are neither Approach nor Avoidance coping.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in general quality of life for cancer patients: EORTC QLQ-C30 v3, in spanish</measure>
    <time_frame>Six months</time_frame>
    <description>Change in quality of life summary score of The European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30).
The EORTC QLQ-C30 questionnaire evaluates the quality of life in oncological population, is composed of both multi-item and single-item measures. It has 30 items, including nine scales: five functional scales (physical, role, emotional, cognitive and social functioning), three symptom scales (fatigue, pain and nausea / vomiting) and one global health status/QoL scale. Six single items are also included (Dyspnea, Insomnia, Appetite loss, Constipation, Diarrhea and Financial difficulties). A high score for all functional and global health/QoL scales represents a high/healthy level of functioning/high QoL, whereas a high score for a symptom scale/item represents a high level of symptoms/problems. The QLQ-C30 was validated in mexican population, obtaining a Crombach's coefficient of 0.7 (Oñate-Ocaña, et al, 2009).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in quality of life for cervical cancer patients: EORTC QLQ-CX 24</measure>
    <time_frame>Six months</time_frame>
    <description>Change in quality of life summary score and subescales using The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Cervical Cancer Module (EORTC QLQ-CX24).
The EORTC QLQ-CX24 is the supplementary module of the QLQ-C30 aimed to evaluate quality of life of cervical cancer patients. It consists of 24 items divided in three multi-item scales to assess symptoms experience (gastrointestinal and genitourinary), body image and sexual/vaginal functioning, and six single items to assess lymphedema, peripheral neuropathy, menopausal symptoms, sexual worry, sexual activity and sexual enjoyment. The last five questions are answered only by patients with an active sex life. Higher scores are equivalent to worse or more symptoms, except for items 49 and 54 (higher score indicates better quality of life). The responses are in a 4-point Likert scale. There is a Spanish version used in Mexican population that was provided by EORTC to use in this study.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in sexual satisfaction in women treated for cervical cancer</measure>
    <time_frame>Six months</time_frame>
    <description>Changes in Screening Questionnaire aimed to identify sexual satisfaction in women treated for cervical cancer Screening questionnaire aimed at identifying sexual satisfaction in women treated for cervical cancer. To explore sexual activity and cognitive distortions about sexuality during and after oncological treatment, with 20 questions in a dichotomous yes/no response. It was developed for this study as part of the semi-structured screening interview in order to determine the cognitions that generate emotional distress and affectation in the quality of life.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in the Factors related to therapeutic adherence</measure>
    <time_frame>Six months</time_frame>
    <description>Changes in the Factors related to therapeutic adherence in cancer patients Scale subscales scores Scale to assess factors related to therapeutic adherence in cancer patients (Urzúa et al., 2012). This scale consists in 20 items measured in a 1-4 point likert scale, it evaluates three factors that may affect the therapeutic adherence of patients to oncological treatment. It has three subescales: a) Expectations and personal tools to face the disease, b) Beliefs about the treatment and c) Perceived effects of the treatment. It was developed especially for oncological population with an internal consistency of alpha=0.96 in the global scale and 0.9, 0.93 and 0.91 for the three subscales.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physiological changes in blood pressure</measure>
    <time_frame>Two months</time_frame>
    <description>Quantitative Changes in the records of physiological measures in which blood pressure (mmHg) are recorded before and after performing the training relaxation exercises.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physiological changes in temperature</measure>
    <time_frame>Two months</time_frame>
    <description>Quantitative Changes in the records of physiological measures in which temperature (Celsius degrees) are recorded before and after performing the training relaxation exercises.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physiological changes in heart rate</measure>
    <time_frame>Two months</time_frame>
    <description>Quantitative Changes in the records of physiological measures in which heart rate (beats/min) are recorded before and after performing the training relaxation exercises.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physiological changes in breathing rate</measure>
    <time_frame>Two months</time_frame>
    <description>Quantitative Changes in the records of physiological measures in which breathing rate (breaths/minute) are recorded before and after performing the training relaxation exercises.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maladaptive thoughts changes</measure>
    <time_frame>During each Cognitive Reestructuring training session</time_frame>
    <description>Qualitative Changes of automatic thoughts during Cognitive Restructuring Technique will be recorded in order to promote &quot;alternative thoughts&quot; according to the Beck Theory for Cognitive Restructuring.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of anxiety, depression, caregiver burden syndrome and quality of life</measure>
    <time_frame>at pretest</time_frame>
    <description>Correlation of the total scores of anxiety, depression, caregiver burden syndrome and quality of life evaluated in the primary Caregiver with the variables of anxiety, depression, coping adherence and quality of life of cervical cancer patients</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">92</enrollment>
  <condition>Cervical Cancer</condition>
  <condition>Psychological Distress</condition>
  <condition>Coping Skills</condition>
  <arm_group>
    <arm_group_label>&quot;A&quot; Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Psychoeducation, Relaxation, Cognitive Reestructuring and Problem Solving</description>
  </arm_group>
  <arm_group>
    <arm_group_label>&quot;B&quot; Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Psychoeducation, Relaxation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Psychoeducation</intervention_name>
    <description>Delivering systematic information about cancer, oncological treatment and efficient coping strategies.</description>
    <arm_group_label>&quot;A&quot; Intervention</arm_group_label>
    <arm_group_label>&quot;B&quot; Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Relaxation</intervention_name>
    <description>Teaching the patient in diaphragmatic breathing retraining and passive relaxation with guided imagination.</description>
    <arm_group_label>&quot;A&quot; Intervention</arm_group_label>
    <arm_group_label>&quot;B&quot; Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cognitive Restructuring</intervention_name>
    <description>Teaching the patient to identify dysfunctional cognitions about cancer and oncological treatment that trigger maladaptive emotions and behavior. Then, focus in generating alternative thoughts through contrast with empirical reality based on the Beck Model.</description>
    <arm_group_label>&quot;A&quot; Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Solving Problems</intervention_name>
    <description>To generate alternative solutions to practical problems based on the model described by Nezu.</description>
    <arm_group_label>&quot;A&quot; Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  PATIENTS:

               -  Affiliated to the MICAELA (Modelo Integral para el Cáncer Cervicouterino
                  Localmente Avanzado y Avanzado) program

               -  Ability to understand the study and to provide signed informed consent

               -  Diagnosed with locally advanced and advanced cervical cancer

               -  Patients newly diagnosed or with recurrence about to start treatment

               -  Patients with moderate or severe anxiety, and/or depression symptoms or
                  maladaptive coping

          -  PRIMARY CAREGIVERS:

               -  Relatives, acquaintance or friends reported to be the principal caregiver of the
                  patient

               -  Relatives, acquaintance or friends who do not perceived economic remuneration for
                  taking care of the patient

        Exclusion Criteria:

          -  PATIENTS:

               -  Patients with psychological or psychiatric treatment or who received previous
                  mental-health treatment.

               -  Patients with any alteration of the Central Nervous System

               -  Patients with moderated or severe cognitive impairment

               -  Patients under palliative care or in terminal phase

          -  PRIMARY CAREGIVERS

               -  Caregivers with severe hearing and/or visual problems

               -  Caregivers with a professional or technical training in patient care

        Elimination criteria Patients referred to palliative care
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mayra S Pérez, BHSc</last_name>
    <role>Study Chair</role>
    <affiliation>National Cancer Institute from Mexico</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lucely C Cetina, MD, MSc</last_name>
    <phone>+52 5556280400</phone>
    <phone_ext>12220</phone_ext>
    <email>lucelycetina.incan@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Roberto Jiménez, MD,MSc</last_name>
    <phone>+52 5554851237</phone>
    <email>jilir@yahoo.com.mx</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Instituto Nacional de Cancerologia</name>
      <address>
        <city>Mexico City</city>
        <state>Tlalpan</state>
        <zip>14080</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Jiménez, MD, MSc</last_name>
      <phone>+52 5554851237</phone>
      <email>jilir@yahoo.com.mx</email>
    </contact>
    <investigator>
      <last_name>Lucely Cetina, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <link>
    <url>https://www.who.int/es/news-room/fact-sheets/detail/cancer</url>
    <description>Organización Mundial de la Salud. Cáncer. Nota descriptiva</description>
  </link>
  <link>
    <url>http://www.diputados.gob.mx/sedia/biblio/usieg/comunicados/salud2.pdf</url>
    <description>Instituto Nacional de Estadística y Geografía. &quot;Estadísticas a propósito del… Día mundial contra el cáncer (4 de febrero)&quot;. Datos nacionales.</description>
  </link>
  <link>
    <url>http://iarc.fr/wp-content/uploads/2019/03/brochureWCR2019-web.pdf</url>
    <description>Stewart B, Wild C. World Cancer Report, [monografía en internet]. Ginebra: WHO-OMS-IARC; 2014</description>
  </link>
  <link>
    <url>http://www.who.int/reproductivehealth/publications/cancers/cervical-cancer-guide/es/</url>
    <description>Organización Mundial de la Salud. Control integral del cáncer cervicouterino: Guía de prácticas esenciales. 2ª ed. [Internet]. Ginebra: OMS; 2015.</description>
  </link>
  <link>
    <url>http://www.researchgate.net/publication/26504787_Aspectos_psicologicos_en_el_cancer_ginecologico</url>
    <description>Olivares M. Aspectos psicológicos en el cáncer ginecológico. Avances en Psicología Latinoamericana. 2004;22:29-48.</description>
  </link>
  <link>
    <url>http://www.medigraphic.com/pdfs/cancer/ca-2000/ca003k.pdf</url>
    <description>Almanza-Muñoz J, Holland J. Psico-oncología: estado actual y perspectivas futuras. Revista del Instituto Nacional de Cancerología. 2000; 43(3) 196-206.</description>
  </link>
  <link>
    <url>http://www.cenetec-difusion.com/CMGPC/IMSS-805-17/ER.pdf</url>
    <description>Secretaría de Salud. Evaluación y abordaje psicooncológico en personas adultas con cáncer en tercer nivel. Ciudad de México: Secretaría de Salud; 16/03/2017.</description>
  </link>
  <link>
    <url>http://scielo.isciii.es/pdf/clinsa/v24n1/original1.pdf</url>
    <description>Hernández M, Cruzado J. La atención psicológica a pacientes con cáncer: de la evaluación al tratamiento. Clínica y Salud. 2013; 24:1-9.</description>
  </link>
  <link>
    <url>http://www.scielo.org.co/pdf/rcc/v19n3/v19n3a06.pdf</url>
    <description>Pousa R, Miguelez A, Hernández B, González T, Gaviria M. Depresión y cáncer: una revisión orientada a la práctica clínica. Revista Colombiana de Cancerología. 2015; 47:1-7</description>
  </link>
  <link>
    <url>https://www.sfu.ac.at/wp-content/uploads/Textbook_of_Psychosomatic_Medicine.pdf</url>
    <description>Massie M. Greenberg D. Oncology. En: Levenson, J. (editores). Textbook of Psychosomatic Medicine. Official textbook of the Academy of Psychosomatic Medicine. 2005. USA: American Psychiatric Publishing. 517-532.</description>
  </link>
  <link>
    <url>http://www.sciencedirect.com/science/article/pii/S0716864017300767</url>
    <description>Rojas O, Fuentes C, Robert V. Psicooncología en el Hospital General. Alcances en depresión y cáncer. Rev. Med. Clin. Condes. 2017;28:450-459.</description>
  </link>
  <link>
    <url>https://medes.com/publication/19455</url>
    <description>Barrohilhet S, Forjaz MJ, Garrido LE. Conceptos, teorías y factores psicosociales en la adaptación al cáncer. Actas Especiales de Psiquiatría. 2005; 33:390-397.</description>
  </link>
  <link>
    <url>http://www.sciencedirect.com/sdfe/reader/pii/S0716864013702074/pdf</url>
    <description>Robert V, Álvarez C, Valdivieso F. Psicooncología: Un modelo de intervención y apoyo psicosocial. Rev. Med. Clin. Condes. 2013;24(4): 677-684.</description>
  </link>
  <link>
    <url>http://dialnet.unirioja.es/servlet/articulo?codigo=4547716</url>
    <description>Rangel-Domínguez NE, Ascencio-Huertas L, Ornelas-Mejorada RE, Allende-Pérez SR, Landa-Ramírez E y Sánchez-Sosa JJ. Efectos de la solución de problemas sobre los comportamientos de autocuidado de cuidadores de pacientes oncológicos en fase paliativa: u</description>
  </link>
  <link>
    <url>http://www.researchgate.net/publication/279225792_Guia_de_practica_clinica_para_la_atencion_psico-oncologica_del_cuidador_primario_informal_de_pacientes_con_cancer</url>
    <description>Galindo VO, Rojas CE, Ascencio HL, Meneses GA, Aguilar PJL, Olvera ME et al. Guía de práctica clínica para la atención psico-oncológica del cuidador primario informal de pacientes con cáncer. Psicooncología. 2015; 12(1): 87-104.</description>
  </link>
  <link>
    <url>http://apps.who.int/iris/bitstream/handle/10665/42682/9241545992.pdf;jsessionid=FCF9F14E637769CD259A34D351F5AD31?sequence=1</url>
    <description>Organización Mundial de la Salud (OMS). Defining Adherence. En: OMS. (2003). Adherence to long-term therapies. Evidence for action. Switzerland: World Health Organization. 2003; 3-9.</description>
  </link>
  <link>
    <url>http://www.researchgate.net/publication/266346247_Adherencia_a_la_quimioterapia_y_radioterapia_en_pacientes_oncologicos_una_revision_de_la_literatura</url>
    <description>Palacios-Espinosa X, Vargas-Sterling LP. Adherencia a la quimioterapia y radioterapia en pacientes oncológicos: Una revisión de la literatura. Psicooncología, 2011:2-3.</description>
  </link>
  <link>
    <url>http://www.researchgate.net/publication/236904641_Validacion_de_una_escala_para_evaluar_factores_vinculados_a_la_adherencia_terapeutica_en_pacientes_oncologicos</url>
    <description>Urzúa MA, Marmolejo CA, Barr DC. Validación de una escala para evaluar factores vinculados a la adherencia terapéutica en pacientes oncológicos. Universitas Psychologica. 2012;11(2):587-598.</description>
  </link>
  <link>
    <url>https://www.redalyc.org/pdf/804/80401403.pdf</url>
    <description>Sánchez R, Ballesteros M, Gómez AA. Medición de la calidad de vida en ensayos clínicos de pacientes con cáncer. Un estudio bibliométrico. Revista Colombiana de Cancerología. 2009; 13(1):29-34. doi: 10.1016/S0123-9015(09)70149-0.</description>
  </link>
  <link>
    <url>http://www.researchgate.net/publication/277271730_La_evaluacion_de_la_calidad_de_vida_del_paciente_oncologico_El_grupo_de_calidad_de_vida_de_la_EORTC</url>
    <description>Arraras JI, Martínez M, Manterota A, Laínez N. La evaluación de la calidad de vida del paciente oncológico. El grupo de calidad de vida de la EORTC. Psicooncología. 2004; 1(1):87-98.</description>
  </link>
  <link>
    <url>http://www.redalyc.org/articulo.oa?id=80615449011</url>
    <description>Pinzón FCE. Cuestionamientos y requerimientos en la investigación de la calidad de vida en oncología. Revista Colombiana de Psiquiatría. 2010; 39(1):153-167.</description>
  </link>
  <link>
    <url>https://www.elsevier.com/books/metodos-de-investigacion-clinica-y-epidemiologica/9788481747096</url>
    <description>Argimón-Pallás J, Jiménez-Villa J. Métodos de investigación clínica y epidemiología. Elsevier.</description>
  </link>
  <link>
    <url>http://www.researchgate.net/publication/282894395_Propiedades_psicometricas_de_la_Escala_Hospitalaria_de_Ansiedad_y_Depresion_HADS_en_una_poblacion_de_pacientes_oncologicos_mexicanos</url>
    <description>Galindo VO, Bejet C, Juárez GF, Rojas CE, Riveros RA, Aguilar PJL et al. Propiedades psicométricas de la Escala Hospitalaria de Ansiedad y Depresión (HADS) en una población de pacientes oncológicos mexicanos. Salud Mental. 2015;38 (4):253-258.</description>
  </link>
  <link>
    <url>http://psicologiaysalud.uv.mx/index.php/psicysalud/article/view/515</url>
    <description>Ornelas RE, Tufiño TMA, Vite SA, Tena GO, Riveros RA, Sánchez-Sosa JJ. Afrontamiento en pacientes con cáncer de mama en radioterapia: análisis de la Escala COPE Breve. Psicología y Salud. 2013;23(1):55-62. DOI: https://doi.org/10.25009/pys.v23i1.515</description>
  </link>
  <link>
    <url>http://www.researchgate.net/publication/290474921_Escala_Hospitalaria_de_Ansiedad_y_Depresion_HADS_en_cuidadores_primarios_informales_de_pacientes_con_cancer_propiedades_psicometricas</url>
    <description>Galindo VO, Meneses GA, Herrera GA, Caballero TR, Aguilar PJL.Escala Hospitalaria de Ansiedad y Depresión (HADS) en cuidadores primarios informales de pacientes con cáncer: propiedades psicométricas. Psicooncología. 2015; 12(2-3) 383-392.</description>
  </link>
  <link>
    <url>http://www.aepcp.net/arc/depresi%C3%B3n%20adultos%202008.pdf</url>
    <description>Grupo de trabajo de la Guía de Práctica Clínica sobre el Manejo de la Depresión en el Adulto. Guía de Práctica Clínica sobre el Manejo de la Depresión en el Adulto. Ministerio de Sanidad, Servicios Sociales e Igualdad. Agencia de Evaluación de Tecnolo</description>
  </link>
  <link>
    <url>http://www.researchgate.net/publication/273686390_Escala_de_carga_del_cuidador_de_Zarit_evidencia_de_validez_en_Mexico</url>
    <description>Montero PX, Jurado CS, Valencia CA, Méndez VJ, Mora MI. Escala de carga del Cuidador de Zarit: Evidencia de Validez en México. Psicooncología. 2014;11(1):71-85. doi: 10.5209/rev_PSIC.2014.v11.n1.44918</description>
  </link>
  <reference>
    <citation>Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.</citation>
    <PMID>25220842</PMID>
  </reference>
  <reference>
    <citation>Die Trill M. Anxiety and sleep disorders in cancer patients. EJC Suppl. 2013 Sep;11(2):216-24. doi: 10.1016/j.ejcsup.2013.07.009. Review.</citation>
    <PMID>26217130</PMID>
  </reference>
  <reference>
    <citation>Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, Meader N. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011 Feb;12(2):160-74. doi: 10.1016/S1470-2045(11)70002-X. Epub 2011 Jan 19.</citation>
    <PMID>21251875</PMID>
  </reference>
  <reference>
    <citation>Henriksson MM, Isometsä ET, Hietanen PS, Aro HM, Lönnqvist JK. Mental disorders in cancer suicides. J Affect Disord. 1995 Dec 24;36(1-2):11-20.</citation>
    <PMID>8988260</PMID>
  </reference>
  <reference>
    <citation>Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry. 2003 Aug 1;54(3):269-82. Review.</citation>
    <PMID>12893103</PMID>
  </reference>
  <reference>
    <citation>Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;(32):57-71. Review.</citation>
    <PMID>15263042</PMID>
  </reference>
  <reference>
    <citation>Jadoon NA, Munir W, Shahzad MA, Choudhry ZS. Assessment of depression and anxiety in adult cancer outpatients: a cross-sectional study. BMC Cancer. 2010 Oct 29;10:594. doi: 10.1186/1471-2407-10-594.</citation>
    <PMID>21034465</PMID>
  </reference>
  <reference>
    <citation>Hinz A, Krauss O, Hauss JP, Höckel M, Kortmann RD, Stolzenburg JU, Schwarz R. Anxiety and depression in cancer patients compared with the general population. Eur J Cancer Care (Engl). 2010 Jul;19(4):522-9. doi: 10.1111/j.1365-2354.2009.01088.x. Epub 2009 Dec 17.</citation>
    <PMID>20030697</PMID>
  </reference>
  <reference>
    <citation>Dauchy S, Dolbeault S, Reich M. Depression in cancer patients. EJC Suppl. 2013 Sep;11(2):205-15. doi: 10.1016/j.ejcsup.2013.07.006. Review.</citation>
    <PMID>26217129</PMID>
  </reference>
  <reference>
    <citation>Pfaendler KS, Wenzel L, Mechanic MB, Penner KR. Cervical cancer survivorship: long-term quality of life and social support. Clin Ther. 2015 Jan 1;37(1):39-48. doi: 10.1016/j.clinthera.2014.11.013. Review.</citation>
    <PMID>25592090</PMID>
  </reference>
  <reference>
    <citation>Manne SL, Virtue SM, Ozga M, Kashy D, Heckman C, Kissane D, Rosenblum N, Morgan M, Rodriquez L. A comparison of two psychological interventions for newly-diagnosed gynecological cancer patients. Gynecol Oncol. 2017 Feb;144(2):354-362. doi: 10.1016/j.ygyno.2016.11.025. Epub 2016 Nov 23.</citation>
    <PMID>27887806</PMID>
  </reference>
  <reference>
    <citation>Moorey S, Frampton M, Greer S. The Cancer Coping Questionnaire: a self-rating scale for measuring the impact of adjuvant psychological therapy on coping behaviour. Psychooncology. 2003 Jun;12(4):331-44.</citation>
    <PMID>12748971</PMID>
  </reference>
  <reference>
    <citation>Watson M, Greer S, Young J, Inayat Q, Burgess C, Robertson B. Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med. 1988 Feb;18(1):203-9.</citation>
    <PMID>3363039</PMID>
  </reference>
  <reference>
    <citation>van Laarhoven HW, Schilderman J, Bleijenberg G, Donders R, Vissers KC, Verhagen CA, Prins JB. Coping, quality of life, depression, and hopelessness in cancer patients in a curative and palliative, end-of-life care setting. Cancer Nurs. 2011 Jul-Aug;34(4):302-14. doi: 10.1097/NCC.0b013e3181f9a040.</citation>
    <PMID>21116179</PMID>
  </reference>
  <reference>
    <citation>Valencia MC, Meza-Osnaya G, Pérez-Cruz I, Cortes-Campero N, Hernández-Ovalle J, Hernández-Paredes P, Juárez-Romero K, Chino-Hernández B, Romero-Figueroa MS. [Factors involved in the burden of the primary caregiver of cancer patients]. Rev Calid Asist. 2017 Jul - Aug;32(4):221-225. doi: 10.1016/j.cali.2016.11.003. Epub 2017 Mar 8. Spanish.</citation>
    <PMID>28284516</PMID>
  </reference>
  <reference>
    <citation>Puts MTE, Tu HA, Tourangeau A, Howell D, Fitch M, Springall E, Alibhai SMH. Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review. Ann Oncol. 2014 Mar;25(3):564-577. doi: 10.1093/annonc/mdt433. Epub 2013 Nov 26. Review.</citation>
    <PMID>24285020</PMID>
  </reference>
  <reference>
    <citation>Osann K, Hsieh S, Nelson EL, Monk BJ, Chase D, Cella D, Wenzel L. Factors associated with poor quality of life among cervical cancer survivors: implications for clinical care and clinical trials. Gynecol Oncol. 2014 Nov;135(2):266-72. doi: 10.1016/j.ygyno.2014.08.036. Epub 2014 Sep 3.</citation>
    <PMID>25192629</PMID>
  </reference>
  <reference>
    <citation>Redd WH, Silberfarb PM, Andersen BL, Andrykowski MA, Bovbjerg DH, Burish TG, Carpenter PJ, Cleeland C, Dolgin M, Levy SM, et al. Physiologic and psychobehavioral research in oncology. Cancer. 1991 Feb 1;67(3 Suppl):813-22. Review.</citation>
    <PMID>1986851</PMID>
  </reference>
  <reference>
    <citation>Barton-Burke M, Gustason CJ. Sexuality in women with cancer. Nurs Clin North Am. 2007 Dec;42(4):531-54; vi. Review.</citation>
    <PMID>17996754</PMID>
  </reference>
  <reference>
    <citation>Baider L, Peretz T, Hadani PE, Koch U. Psychological intervention in cancer patients: a randomized study. Gen Hosp Psychiatry. 2001 Sep-Oct;23(5):272-7.</citation>
    <PMID>11600169</PMID>
  </reference>
  <reference>
    <citation>Hopko DR, Bell JL, Armento M, Robertson S, Mullane C, Wolf N, Lejuez CW. Cognitive-behavior therapy for depressed cancer patients in a medical care setting. Behav Ther. 2008 Jun;39(2):126-36. doi: 10.1016/j.beth.2007.05.007. Epub 2007 Oct 31.</citation>
    <PMID>18502246</PMID>
  </reference>
  <reference>
    <citation>Goerling U, Foerg A, Sander S, Schramm N, Schlag PM. The impact of short-term psycho-oncological interventions on the psychological outcome of cancer patients of a surgical-oncology department - a randomised controlled study. Eur J Cancer. 2011 Sep;47(13):2009-14. doi: 10.1016/j.ejca.2011.04.031. Epub 2011 May 24.</citation>
    <PMID>21612912</PMID>
  </reference>
  <reference>
    <citation>de la Torre-Luque A, Gambara H, López E, Cruzado JA. Psychological treatments to improve quality of life in cancer contexts: A meta-analysis. Int J Clin Health Psychol. 2016 May-Aug;16(2):211-219. doi: 10.1016/j.ijchp.2015.07.005. Epub 2015 Aug 29.</citation>
    <PMID>30487864</PMID>
  </reference>
  <reference>
    <citation>Rehse B, Pukrop R. Effects of psychosocial interventions on quality of life in adult cancer patients: meta analysis of 37 published controlled outcome studies. Patient Educ Couns. 2003 Jun;50(2):179-86.</citation>
    <PMID>12781933</PMID>
  </reference>
  <reference>
    <citation>Manne SL, Rubin S, Edelson M, Rosenblum N, Bergman C, Hernandez E, Carlson J, Rocereto T, Winkel G. Coping and communication-enhancing intervention versus supportive counseling for women diagnosed with gynecological cancers. J Consult Clin Psychol. 2007 Aug;75(4):615-628. doi: 10.1037/0022-006X.75.4.615.</citation>
    <PMID>17663615</PMID>
  </reference>
  <reference>
    <citation>Galindo-Vazquez O, Benjet C, Cruz-Nieto MH, Rojas-Castillo E, Riveros-Rosas A, Meneses-Garcia A, Aguilar-Ponce JL, Alvarez-Avitia MA, Alvarado-Aguilar S. Psychometric properties of the Zarit Burden Interview in Mexican caregivers of cancer patients. Psychooncology. 2015 May;24(5):612-5. doi: 10.1002/pon.3686. Epub 2014 Sep 29.</citation>
    <PMID>25263699</PMID>
  </reference>
  <reference>
    <citation>Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001 Apr 14;357(9263):1191-4.</citation>
    <PMID>11323066</PMID>
  </reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>October 7, 2019</study_first_submitted>
  <study_first_submitted_qc>November 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2019</study_first_posted>
  <last_update_submitted>May 25, 2020</last_update_submitted>
  <last_update_submitted_qc>May 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Institute of Cancerología</investigator_affiliation>
    <investigator_full_name>Dr. Lucely Cetina Pérez</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Cervical cancer</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Coping</keyword>
  <keyword>Distress</keyword>
  <keyword>Anxiety</keyword>
  <keyword>Depression</keyword>
  <keyword>Therapeutic adherence</keyword>
  <keyword>Sexual Satisfaction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

